1.
Nickel JC, Kelly K-L, Griffin A, Elterman DS, Clark-Pereira J, Doiron RC. MV140 sublingual vaccine reduces recurrent urinary tract infection in women: Results from the first North American clinical experience study. CUAJ [Internet]. 2023 Oct. 23 [cited 2026 May 2];18(2):25-31. Available from: https://cuaj.ca/index.php/journal/article/view/8455